Phase 2 Gaucher Disease Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Clinical Trial of PR001 (LY3884961) in Patients With Peripheral Manifestations of Gaucher Disease (PROCEED)
Gaucher Disease
Prevail Therapeutics15 enrolled8 locationsNCT05487599
Recruiting
Phase 1Phase 2
A Clinical Study Evaluating LY-M001 Injection in the Treatment of Adult Patients With Type I Gaucher Disease
Gaucher Disease Type 1
Lingyi Biotech Co., Ltd.12 enrolled3 locationsNCT06818838